Employing epigenetic protein degradation techniques to block CCL5-mediated photodynamic therapy via a programmed delivery platform

Key Points

• Blocking CCL5 enhances the effectiveness of photodynamic therapy, potentially improving patient outcomes.
• The use of epigenetic protein degradation techniques shows significant promise for targeted therapeutic interventions.
• Programmed delivery systems were employed to efficiently localize treatment effects on cancer cells, optimizing therapy.
• This approach may enable personalized treatment strategies, although further validation in larger clinical settings is required.